한국어
English
日本語
中文(简体)
Mao Bi Tablet (Selegiline Hydrochloride)
5mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.
Selegiline hydrochloride is a central nervous system modulator used in the treatment of Parkinson's disease.
MFDS ingredient code M222864
Selegiline hydrochloride is a medication used in the treatment of Parkinson's disease that selectively inhibits MAO-B, an enzyme that breaks down dopamine in the brain. This component helps regulate central nervous system function to improve motor skills.
Selegiline hydrochloride selectively inhibits MAO-B, the enzyme that breaks down dopamine in the brain. As a result, dopamine levels increase, leading to improved neural signaling and alleviation of Parkinson's disease symptoms.
Approved uses differ by product. Check each product's information for its actual use.
Unlike non-selective MAO inhibitors, selegiline specifically inhibits only MAO-B, resulting in fewer side effects and a specialization in dopamine function. This characteristic distinguishes it from other MAO inhibitors.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.